Anacin is an American brand of analgesic that is manufactured by Prestige Consumer Healthcare. Its product contains aspirin and caffeine. History
Anacin was invented by William Milton Knight and was first to be used circa 1916 as stated in the patent. Anacin is one of the oldest brands of pain relievers in the United States, first being sold in the 1930s. Anacins mascot at the time was Ana Anacin, who was found in a number of ads for this product by Bayer. It was originally sold by the Anacin Co. ("Pharmaceutical Chemists") in Chicago, Illinois. American Home Products, now known as Wyeth, purchased the manufacturing rights in 1930. Anacin was reportedly their most popular product. Insight Pharmaceuticals acquired the brand in 2003. In 2014, Prestige Brands signed an agreement with Insight to acquire the company; it was Prestige Brands largest acquisition to that point. Advertising
In 1939, Anacin sponsored a daytime serial called Our Gal Sunday. Their sponsorship spanned 18 of the programs 23 years on the air. Early Anacin radio commercials appeared in radio shows and dramas of the 1940s and 50s. These "formulaic" commercials usually claimed that Anacin was being actively prescribed by doctors and dentists at the time, treated "headaches, neuritis and neuralgia", and that it contained "a combination of medically proven ingredients, like a doctors prescription", without specifying those ingredients. Sometimes the announcer would mention that there were four active ingredients in Anacin, one of which was the medicine the consumer was already taking. It also claimed to help with depression.
Retained placenta is a condition in which all or part of the placenta or membranes remain in the uterus during the third stage of labour. Retained placenta can be broadly divided into:

failed separation of the placenta from the uterine lining
placenta separated from the uterine lining but retained within the uterusA retained placenta is commonly a cause of postpartum haemorrhage, both primary and secondary.Retained placenta is generally defined as a placenta that has not undergone placental expulsion within 30 minutes of the baby’s birth where the third stage of labor has been managed actively. Signs and symptoms
Risks of retained placenta include hemorrhage and infection. After the placenta is delivered, the uterus should contract down to close off all the blood vessels inside the uterus. If the placenta only partially separates, the uterus cannot contract properly, so the blood vessels inside will continue to bleed. A retained placenta thereby leads to hemorrhage. Management
Drugs, such as intraumbilical or intravenous oxytocin, are often used in the management of placental retention. It is useful ensuring the bladder is empty. However, ergometrine should not be given as it causes tonic uterine contractions which may delay placental expulsion. Controlled cord traction has been recommended as a second alternative after more than 30 minutes have passed after stimulation of uterine contractions, provided the uterus is contracted. Manual extraction may be required if cord traction also fails, or if heavy ongoing bleeding occurs.